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Clock circadian regulator (CLOCK)/brain and muscle arnt-like protein-1 (BMAL1) complex governs the regulation of
circadian rhythm through triggering periodic alterations of gene expression. However, the underlying mechanism
of circadian clock disruption in hepatocellular carcinoma (HCC) remains unclear. Here, we report that a long
noncoding RNA (lncRNA), highly upregulated in liver cancer (HULC), contributes to the perturbations in circadian
rhythm of hepatoma cells. Our observations showed that HULC was able to heighten the expression levels of
CLOCK and its downstream circadian oscillators, such as period circadian clock 1 and cryptochrome circadian
clock 1, in hepatoma cells. Strikingly, HULC altered the expression pattern and prolonged the periodic expression
of CLOCK in hepatoma cells. Mechanistically, the complementary base pairing between HULC and the 5'
untranslated region of CLOCK mRNA underlay the HULC-modulated expression of CLOCK, and the mutants in the
complementary region failed to achieve the event. Moreover, immunohistochemistry staining and quantitative real-
time polymerase chain reaction validated that the levels of CLOCK were elevated in HCC tissues, and the
expression levels of HULC were positively associated with those of CLOCK in clinical HCC samples. In functional
experiments, our data exhibited that CLOCK was implicated in the HULC-accelerated proliferation of hepatoma
cells in vitro and in vivo. Taken together, our data show that an lncRNA, HULC, is responsible for the perturbations
in circadian rhythm through upregulating circadian oscillator CLOCK in hepatoma cells, resulting in the promotion
of hepatocarcinogenesis. Thus, our finding provides new insights into the mechanism by which lncRNA
accelerates hepatocarcinogenesis through disturbing circadian rhythm of HCC.
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Hepatocellular carcinoma (HCC) is the major histologic subtype of
primary liver cancer, accounting for 70% to 85% of cases in most
countries, and a leading cause of cancer deaths every year worldwide
[1,2]. It has been reported that the chronic exposure to toxic
chemicals, chronic infections with hepatitis B virus (HBV) or
hepatitis C virus, as well as hepatosteatosis are the major risk factors
for HCC [3,4]. A recent study describes that disturbance of circadian
gene expression is exhibited in HCC [5], indicating that the
development of HCC impacts the orchestrated circadian rhythm of
liver cells. However, the major cause and the underlying mechanism
of circadian rhythm disorders of HCC remain a mystery. In response
to the daily 24-hour light–dark cycle, living organisms have developed
an evolutionarily conserved program that coordinates body systems
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the cellular level, these rhythms are controlled by transcriptional
feedback loops that produce fluctuations in gene expression, a process
associated with circadian changes in chromatin architecture,
messenger RNA (mRNA) processing, protein activity, and protein
turnover [8]. In mammals, the transcription factors clock circadian
regulator (CLOCK) and brain and muscle arnt-like protein-1
(BMAL1) drive the central oscillator within the hypothalamus and
even in peripheral tissue [9]. At the core, CLOCK and BMAL1, the
basic helix–loop–helix (bHLH)-PAS domain transcription factors,
form a heterodimer to drive rhythmic expression of genes harboring
E-box elements in their promoter [10,11]. Notably, as a peripheral
tissue, liver itself is a biological clock capable of actually generating
diurnal rhythms [12]. Approximately, 10% of genes are rhythmic in
the liver, driven by the circadian clock. More recent RNA-sequencing
data have shown that, of these rhythmic genes, only about a fifth is
driven by de novo transcription, indicating that posttranscriptional
regulation plays crucial roles in this event [13]. Heretofore, the role of
circadian oscillators, such as CLOCK, in hepatocarcinogenesis has
not been well documented.
The non–protein-coding portion of the mammalian genome is
transcribed into a vast array of RNA species [14]. Among them, long
noncoding RNAs (lncRNAs)—defined as transcribed RNA mole-
cules larger than 200 nt in length—are poorly conserved expression
by diverse mechanisms [15–17]. Many of the identified lncRNAs
show spatial- and temporal-specific patterns of expression, indicating
that lncRNA expression is strongly regulated. Alterations in the
primary structure, secondary structure, and expression levels of
lncRNAs as well as their cognate RNA-binding proteins underlie
diseases ranging from neurodegeneration to cancer [18,19], suggest-
ing that lncRNAs emerge as vital modulators in physiologic and
pathologic states. Regulation of gene expression by lncRNAs can be
mediated at transcriptional step and posttranscriptional step [20].
Nevertheless, whether lncRNAs participate in the modification of
circadian rhythm of hepatoma cells remains largely unknown.
In the current article, we are interested in the role of lncRNAs in
circadian rhythm disorders of HCC. We show that HULC, an
lncRNA overexpressed in HCC, enhances the hepatocarcinogenesis
through disturbing the circadian rhythm of hepatoma cells. HULC
alters the expression pattern and prolongs the periodic expression of
circadian oscillator CLOCK in hepatoma cells. Our finding provides
new insights into the mechanism by which lncRNA accelerates
hepatocarcinogenesis through perturbing circadian rhythm of HCC.
Materials and Methods
Patient Samples
Twenty HCC tissues and their corresponding nearby nontumor-
ous liver tissues and 10 HCC tissues used in this study were obtained
from Tianjin First Center Hospital (Tianjin, China) after surgical
resection. Written consents approving the use of their tissues for
research purposes were obtained from patients. The study protocol
was approved by the Institute Research Ethics Committee at the
Nankai University.
Cell Lines and Cell Culture
The human immortalized liver L-O2 cell line and L-O2-X cell line
were cultured in PRMI-1640 medium (Gibco, CA). The human
hepatoma cell lines, HepG2 and HepG2.2.15 (a hepatoma HepG2
cell line integrated full-length HBV DNA), were maintained inDulbecco’s modified Eagle’s medium (Gibco). All of these cell lines
were supplemented with heat-inactivated 10% fetal bovine serum
(Gibco), 100 U/ml penicillin, and 100 mg/ml streptomycin in 5%
CO2 at 37°C.
Plasmid Construction
The full-length HULC was amplified from cDNA of HepG2 cells
and then cloned into pcDNA3.1 vector. The resulting vector was
sequenced and named pcDNA3.1-HULC. The HULC containing
the mutant in (or out of) complementary region between HULC and
CLOCK 5′ untranslated region (UTR) was constructed (termed as
HULC-mut-in or HULC-mut-out). All primers are listed in
Supplementary Table S1.
One ~150–base pair fragment of CLOCK 5′UTR was subcloned
into pGL3-control vector (Promega, Madison, WI) immediately
upstream of the start codon of the luciferase gene to generate pGL3-
CL-5′UTR. Mutant construct of complementary region of CLOCK
5′UTR (named pGL3-CL-5′UTR-mut), carrying a substitution of
16 nucleotides within the complementary region between HULC and
CLOCK 5′UTR, was conducted by using overlapping extension
polymerase chain reaction (PCR). All primers are listed in
Supplementary Table S1.
Cell Transfection
The cells were cultured in a 6-well or 24-well plate for 24 hours
and then were transfected with plasmids or siRNAs. All transfections
were performed using Lipofectamine 2000 reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s protocol. siRNA
oligonucleotides, including targeting HULC (or CLOCK) and a
nonspecific scrambled control (si-Ctrl), were synthesized by RiboBio
(Guangzhou, China). The siRNA duplexes sequences are all listed in
Supplementary Table S1.
Quantitative Real-Time PCR (qRT-PCR)
Total RNA was extracted from the cells (or tissues) using Trizol
(Invitrogen) according to the manufacturer’s protocol. Reverse
transcription was performed using poly(A)-tailed total RNA and
reverse transcription primer with ImPro-IIReverse Transcriptase
(Promega) according to the manufacturer’s instructions. The qRT-
PCR was performed as described in the method of Fast Start
Universal SYBR Green Master (Rox) (Roche Diagnostics GmbH,
Mannheim, Germany). GAPDH was used as the control for qRT-
PCR. All primers are listed in Supplementary Table S1.
Luciferase Reporter Gene Assays
Luciferase reporter gene assays were performed using the Dual-
Luciferase Reporter Assay System (Promega) according to the
manufacturer’s instructions. Briefly, cells were cultured in 24-well
plates at 3× 104 cells per well. After 24 hours, the cells were transiently
co-transfected with the pRL-TK plasmid (Promega) containing the
Renilla luciferase gene, which is used for internal normalization, and
with various constructs containing different sequence of CLOCK 5′
UTR (or pGL3-control) or various constructs of wild and mutant
HULC. All experiments were performed at least three times.
Western Blot Analysis
Western blot analysis protocol was described previously [21]. The
primary antibodies used were mouse anti–β-actin (Sigma, St Louis,
MO) and rabbit anti-CLOCK (Proteintech Group, Chicago, IL). All
experiments were repeated at least three times.
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The HCC tissue and peritumor liver tissue microarrays were
obtained from the Xi'an Aomei Biotechnology Co, Ltd (Xi'an,
China). These microarrays were composed of 33 HCC tissues and 4
peritumor liver tissues, which included duplicate core biopsies (1 mm
in diameter) from fixed, paraffin-embedded tumors. Immunohisto-
chemical staining of samples was performed as previously reported
[22], and the primary antibody of rabbit anti-CLOCK (ProteintechFigure 1. HULC upregulates CLOCK and perturbs its rhythmical expres
examined byWestern blotting in L-O2 and HepG2 cells transfected wi
transfection efficiency of HULC was detected by qRT-PCR. (C) The
HepG2.2.15 cells transfected with CLOCK siRNA. The interference e
(D) The effect of HULC on the expression of downstream target gene
and L-O2 cells. (E and F) The effect of HULC on rhythmical expressi
during 24 hours, respectively. Statistically significant differences areGroup) or primary antibody of rabbit anti-Ki-67 (Cell Signaling
Technology, Beverly, MA) was used. The extents of cytosolic staining
were considered in the scoring. The percentage of immunoreactivity
in tumor cells or hepatocytes was graded as: 0 (b10%); 1, low (10%
to 30%); 2, intermediate (30% to 50%); 3, high (N50%).
Categorization of immunostaining intensity was performed by three
independent observers. The medical records of the patients were listed
in Supplementary Table S2.sion in hepatoma cells. (A and B) The protein levels of CLOCK were
th pcDNA3.1-HULC (termed as HULC), respectively. Meanwhile, the
protein levels of CLOCK were examined by Western blotting in
fficiency of CLOCK siRNA was detected by qRT-PCR in the cells.
s of CLOCK, PER1 and CRY1, was measured by qRT-PCR in HepG2
on of CLOCK was assessed by qRT-PCR in L-O2 and HepG2 cells
indicated: **P b .01, ***P b .001; Student’s t test.
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(MTT) Assays
HepG2 cells were seeded onto 96-well plates (1000 cells/well) for
24 hours before transfection, and MTT assays were used to assess cell
proliferation every day from the first day until the third day after
transfection. The protocol was described previously [23].
Flow Cytometry Analysis
Forty-eight hours after transfection, the cells (1× 106) were
harvested and washed with cold PBS twice. Washed cells were fixed in
75% ethanol at 4°C overnight. The fixed cells were rinsed twice with
PBS and treated with propidium iodine solution including 50 μg/ml
propidium iodine (Sigma) and 50 μg/ml RNaseA (Sigma) at 37°C for
60 minutes. Stained cells were analyzed by a FACScan flow cytometer
(Becton Dickinson, Bedford, MA).
Cloning Formation Assays
For clonogenicity analysis, 48 hours after transfection, 500 viable
transfected cells were placed in six-well plates and maintained inFigure 2. HULC interacts with the 5'UTR of CLOCK mRNA via comp
complementary region between HULC and CLOCK 5'UTR by bioinform
the complementary region between HULC and CLOCK 5'UTR were m
Western blotting in L-O2 cells transfected with HULC-mut-in (or HULC
(or HULC-mut-out) was detected by qRT-PCR in the cells. (D and E)
significant differences are indicated: **P b .01; Student’s t test.complete medium for 2 weeks. Colonies were fixed with methanol
and stained with methylene blue.
Soft Agar Assays
Anchorage-independent cell growth was assessed by the soft agar
assays. Briefly, 2 ml of 0.5% agar was added to each well of a 6-well
plate. Detached LO-2 (LO-2-HULC) cells were mixed with an
agarose suspension (0.3% final concentration) and then layered onto
the 0.5% agarose underlay. Culture medium was changed every
3 days, and the number of cell foci ≥100 mm in diameter was
counted after 21 days.
In Vivo Tumorigenicity Assays
Nude mice were housed and treated according to guidelines
established by the National Institutes of Health Guide for the Care
and Use of Laboratory Animals. We conducted the animal
transplantation according to the Declaration of Helsinki. Briefly,
pretreated HepG2 cells (treated with pcDNA3.1, pcDNA3.1-
HULC, or pcDNA3.1-HULC and CLOCK siRNA) were harvestedlementary base pairing in hepatoma cells. (A) A model shows the
atics prediction, in which the generated mutant sites in (or out of)
arked. (B and C) The protein levels of CLOCK were measured by
-mut-out), respectively. The transfection efficiency of HULC-mut-in
The experiments above were repeated in HepG2 cells. Statistically
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saline. Three groups of 4-week-old male BALB/c athymic nude mice
(Experiment Animal Center of Peking, China) (each group, n=6)
were subcutaneously injected at the shoulder with 0.2 ml of the cell
suspensions. Tumor growth was measured after 5 days from
injection and then every 5 days. Tumor volume (V) was monitored
by measuring the length (L) and width (W) with calipers and
calculated with the formula (L × W2) × 0.5. After 25 days, tumor-
bearing mice and controls were sacrificed, and the tumors were
excised and measured.
Statistical Analysis
Each experiment was repeated at least three times. Statistical
significance was assessed by comparing mean values (6 SD) using a
Student’s t test for independent groups and was assumed for *P b .05,
**P b .01, and ***P b .001, no significant (NS). Pearson correlation
coefficient was used to determine the correlation between the
expressions of HULC and CLOCK in tumorous tissues. CLOCK
expression in tumor tissues and matched adjacent nontumor tissues
was compared using Wilcoxon signed-rank test.Figure 3. The 5'UTR of CLOCK mRNA interacts with HULC via comp
complementary region between HULC and CLOCK 5'UTR. Schematic
complementary region binding to HULC, which is inserted in pGL3-co
(or pGL3-CL-5'UTR-mut) was examined by luciferase reporter gene a
pGL3-CL-5'UTR (or pGL3-CL-5'UTR-mut) was measured by luciferase r
X cells. (D and E) The experiments above were repeated in HepG2 and
**P b .01, no significance (NS); Student’s t test.Results
HULC Upregulates CLOCK and Perturbs Its Rhythmical
Expression in Hepatoma Cells
Given that the heterodimer of CLOCK/BMAL1 is essential for the
modulation of circadian rhythm [9], we evaluated the endogenous
expression levels of CLOCK and BMAL1 in L-O2 and HepG2 cells.
qRT-PCR assays manifested that the endogenous levels of BMAL1
were much higher than those of CLOCK in the cells (Supplementary
Figure S1A), suggesting that CLOCK might be the limitative
component in the formation of the heterodimer. Moreover, the
transient transfection of HULC resulted in the upregulation of
CLOCK but failed to affect the expression of BMAL1 in hepatoma
cells (Supplementary Figure S1B). Therefore, we focused on the
investigation of CLOCK in the cells. qRT-PCR andWestern blotting
showed that HULC was able to heighten the expression levels of
CLOCK after 32 hours of transfection in L-O2 and HepG2 cells in a
dose-dependent manner (Supplementary Figure S1C; Figure 1, A
and B). Because HepG2.2.15 cells contained high levels of
endogenous HULC [24], we observed that HULC siRNA dose-lementary base pairing in hepatoma cells. (A) A model shows the
diagram exhibits the generated mutant site at the CLOCK 5'UTR in
ntrol vector. (B) The effect of HULC on reporters of pGL3-CL-5'UTR
ssays in L-O2 cells. (C) The effect of HULC siRNA on reporters of
eporter gene assays in HBx-elevated HULC-highly-expressing L-O2-
HepG2.2.15 cells. Statistically significant differences are indicated:
Figure 4. The expression levels of HULC are positively correlated
with those of CLOCK in clinical HCC tissues. (A) The expression of
CLOCK was examined by IHC staining in clinical HCC tissues and
peritumor tissues using tissue microarray. Representative example
of IHC observed in peritumor tissues and HCC tissues using rabbit
anti-CLOCK Ab. (B) The relative mRNA levels of CLOCK were
assessed by qRT-PCR in 20 pairs of clinical HCC tissues and
corresponding nontumorous tissues (**P b .01; Wilcoxon signed-
rank test). (C) The correlation of HULC mRNA levels with CLOCK
mRNA levels was examined by qRT-PCR in 30 cases of clinical HCC
tissues (**P b .01; Pearson correlation coefficient, r=0.6532).
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cells (Supplementary Figure S1B, Figure 1C ). Meanwhile, the
transfection (or interference) efficiency of HULC (or HULC siRNA)
was verified by qRT-PCR in the cells (Figure 1, A–C ). To further
validate above outcomes, we examined the effect of HULC on the
downstream factors of CLOCK in hepatoma cells. It has been reported
that period circadian clock 1 (PER1) and cryptochrome circadian clock
1 (CRY1) are clock genes regulated by CLOCK/BMAL1 [25–27]. As
expected, qRT-PCR assays exhibited that HULC upregulated the
expression of PER1 and CRY1 in L-O2 and HepG2 cells (Figure 1D),
indicating that HULC is able to upregulate CLOCK in hepatoma cells.
To dissect the influence of HULC in circadian rhythm of
hepatoma cells, we observed the effect of HULC on CLOCK during
the period of 24 hours in L-O2 and HepG2 cells according to the
previous report of measuring time [9]. We transfected HULC into L-
O2 and HepG2 cells and extracted the mRNA at 4-hour intervals.
Intriguingly, the expression of CLOCK displayed two peaks during
24 hours in L-O2 and HepG2 cells. The expression peaks of CLOCK
were present at 8 hours (peak I) and 20 hours (peak II) in L-O2 cells,
whereas HepG2 cells showed peak I at 4 hours and peak II at
20 hours. Importantly, we observed that the overexpression of HULC
advanced the expression peak I of CLOCK from 8 to 4 hours in L-O2
cells and delayed the peak II over 4 hours in the cells; however, in
HepG2 cells, the overexpression of HULC delayed the expression of
peaks I and II of CLOCK over 4 hours (Figure 1, E and F ),
suggesting that the HULC-disturbed rhythm is different in hepatoma
cells and normal liver cells. In addition, HULC prolonged the
expression period of CLOCK in L-O2 and HepG2 cells (Figure 1, E
and F ). Thus, we conclude that HULC perturbs the rhythmical
expression of CLOCK in hepatoma cells and modifies the CLOCK
expression pattern of hepatic cells.
HULCTargets the 5'UTR of CLOCKmRNAviaComplementary
Base Pairing in Hepatoma Cells
Next, we undertook to nail the underlying mechanism of HULC
eliciting CLOCK. A previous study described that lncRNA interacted
with and stabilized mRNA [28], and RNA structure in the UTRs of
mRNAs influences posttranscriptional regulation of gene expres-
sion [29]. Therefore, we are interested in whether HULC governs the
expression of CLOCK at posttranscriptional step through interacting
with themRNAofCLOCK.Thus, we screened the sequence ofHULC
andCLOCKusing bioinformatics (http://blast.ncbi.nlm.nih.gov/Blast.
cgi). Notably, we obtained a complementary area about 16 nt between
HULC and the 5'UTR of CLOCK mRNA. Accordingly, we
conjectured that the complementary region might underlie the
modulation of CLOCK by HULC.
To verify the assumption, we constructed two mutants of HULC
into pcDNA3.1. One mutant was changed in the sequence of
complementary region (termed HULC-mut-in); the other was altered
in the sequence nearby the complementary region (termed HULC-
mut-out) (Figure 2A). Interestingly, our data revealed that HULC-
mut-in lost the function in L-O2 and HepG2 cells relative to wild-
type HULC after 32-hour transfection (Figure 2, B and D).
However, the HULC-mut-out still heightened the expression of
CLOCK in the cells in a dose-dependent manner (Figure 2, C
and E ). Moreover, we cloned the 5'UTR of CLOCK mRNA
containing the complementary region and the relative mutant into
pGL3-control (termed pGL3-CL-5'UTR and pGL3-CL-5'UTR-
mut) individually (Figure 3A). Luciferase reporter gene assaysindicated that HULC was able to increase the activities of pGL3-
CL-5'UTR in a dose-dependent manner but unaltered those of
pGL3-CL-5'UTR-mut in L-O2 and HepG2 cells (Figure 3, B and
D). Inversely, the activities of pGL3-CL-5'UTR were petered out by
treatment with HULC siRNA in HBV X gene stably transfected L-
O2-X (expressing a high level of endogenous HULC) [24] and
HepG2.2.15 cells, whereas HULC siRNA failed to influence the
activity of pGL3-CL-5'UTR-mut in the system (Figure 3, C and E ).
In addition, the downstream target genes of CLOCK, such as PER1
and CRY1 [30], were upregulated by HULC (or HULC-mut-out)
but not by HULC-mut-in in HepG2 cells after 32-hour transfection
(Supplementary Figure S2, A and B). Together, we conclude that the
complementary region between HULC and the 5'UTR of CLOCK
mRNA is required for the modulation of CLOCK mediated by
HULC.
The Expression Levels of HULC Are Positively Correlated with
Those of CLOCK in Clinical HCC Tissues
Next, we assessed the expression relationships between HULC and
CLOCK in clinical HCC tissues. Noticeably, immunohistochemical
staining manifested that the positive rate of CLOCK was 75.76%
(25/33) in HCC tissues using tissue microarrays. One out of four was
positive in the peritumor liver tissues (Figure 4A). Meanwhile, qRT-
PCR showed that the mRNA levels of CLOCK were higher in HCC
tissues compared with those in their adjacent nontumorous liver
tissues in 20 paired clinical samples (Figure 4B). The levels of HULC
were positively related to those of CLOCK in 30 cases of clinical
HCC tissues (Figure 4C ). Thus, we conclude that the expression
of HULC is positively related to that of CLOCK in clinical liver
cancer tissues.
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Mediated by HULC In Vitro and In Vivo
Given that dysregulation of the circadian rhythm is implicated in
many types of cancers [31], we are interested in whether CLOCK is
involved in the proliferation of hepatoma cells mediated by HULC.
Luciferase reporter gene assays illustrated that HULC-mut-in was
unable to affect the activity of pGL3-CL-5'UTR, whereas HULC-
mut-out worked well in HepG2 cells in a dose-dependent manner
(Figure 5A). Moreover, MTT assays corroborated that CLOCK
siRNA was capable of blocking the HULC-enhanced proliferation of
hepatoma cells (Figure 5B). In addition, cell cycle analysis by flow
cytometry showed that HULC resulted in the increase of S-phase
HepG2 cells from 15.75% to 35.94%. Notably, CLOCK siRNA
inhibited the effect of HULC on the S-phase HepG2 cells, decreasingFigure 5. CLOCK is required for HULC-accelerated proliferation of he
out) on reporters of pGL3-CL-5'UTR was assessed by luciferase rep
measured by MTT assays, flow cytometry, and cloning formation
individually. (E) The effect of HULC on the neoplastic transformation in
differences are indicated: *P b .05, **P b .01, NS; Student’s t test.from 35.94% to 22.15% (Figure 5C ). Clone formation assay revealed
that HULC siRNA was able to block the proliferation of HepG2 cells.
Moreover, CLOCK siRNA potently abolished HULC-strengthened
proliferation of HepG2 cells (Figure 5D). Meanwhile, the interference
efficiency of CLOCK siRNA (or CLOCK siRNA*) was validated by
Western blotting in the cells (Supplementary Figure S3A). Moreover,
soft agar assays exhibited that the efficiency of LO-2 cells to generate
colonies by anchorage-independent growth in a semisolid medium
was remarkably heightened by overexpressing HULC (Figure 5E ).
Together, our observations suggest that CLOCK is implicated in the
proliferation of hepatoma cells in vitro.
Next, we evaluated the effect of CLOCK on the tumor growth
mediated by HULC in mouse models. Notably, we observed that the
volume and weight of tumors were remarkably elevated in the grouppatoma cells in vitro. (A) The effect of HULC-mut-in (or HULC-mut-
orter gene assays in HepG2 cells. (B–D) The cell proliferation was
in HepG2 cells transfected with HULC (or HULC/CLOCK siRNA)
LO-2 cells was detected by soft agar assays. Statistically significant
86 HULC disturbs the circadian rhythm of HCC Cui et al. Neoplasia Vol. 17, No. 1, 2015of HULC pretreated HepG2 cells relative to control group.
Strikingly, our data exhibited that CLOCK siRNA markedly
eliminated the tumor growth enhanced by HULC in nude mice
(Figure 6, A–C). Moreover, IHC further confirmed that the
expression of Ki-67, a marker of proliferation, in the tumor tissues
was reconciled with the tumor growth (Supplementary Figure S3B).
Meanwhile, our data validated that the levels of HULC and CLOCK
were corresponding to the treatment in the tumor tissues from mice
(Figure 6, D and E). Thereby, we conclude that CLOCK is required
for the proliferation of hepatoma cells mediated by HULC in vitro
and in vivo.
Discussion
The altered circadian rhythm accompanies stages of cancer
progression. However, the role of a circadian oscillator, CLOCK, in
liver cancer remains poorly understood. A spot of characterized
human lncRNAs, which emerged as regulatory RNAs, has been
associated with a spectrum of biological functions, and the disruption
of these functions has critical roles in the development of cancer [32].
In this study, we are interested in whether lncRNA perturbs the
circadian rhythm of HCC.
Previous studies pointed out that HULC, as an lncRNA, was
overexpressed in HCC tissues and was governed by an RNA-binding
protein IGF2BPs [33,34].Our group has reported thatHULC is able to
accelerate the growth of HCC through downregulating its neighbor
gene p18 [24]. Here, we were curious whether HULC participates in
the circadian rhythm disturbance in liver cancer. Strikingly, we found
that HULC was able to heighten the expression levels of CLOCK and
prolong the periodic expression of CLOCK in hepatoma cells.Figure 6. CLOCK is required for HULC-accelerated proliferation of hep
nude mice and their growth curve, respectively. (C) The average wei
CLOCK were detected by qRT-PCR and Western blotting in the tumor
are indicated: **P b .01, NS; Student’s t test.Importantly, HULC altered the expression pattern and prolonged the
periodic expression of CLOCK in the cells. The expression patterns of
CLOCK were different in LO-2 and HepG2 overexpressing HULC,
however, suggesting that the cell context might influence the cell
behavior to the stimulation. Previous studies described that lncRNAs
were implicated in the development and differentiation of human cells
[35]; their inaccurate expression could lead to disease [36,37]. In the
present article, we observed that the disturbance of circadian rhythm in
LO-2 cells mediated by HULC led to the promotion of malignance
abilities of liver cells in vitro. Collectively, we first provide evidence that
an lncRNA HULC disturbs the circadian rhythm of hepatocellular
carcinima through upregulating oscillator CLOCK.
LncRNAs serve as modulators to control the physiologic and
pathologic progresses. Given that lncRNAs are poorly conserved and
control the expression of genes in vatious manners, such as
posttranscriptional gene regulation through controlling processes like
protein synthesis, RNA maturation and transport, and, very recently, in
transcriptional gene silencing through regulating the chromatin
structure [16]. In addition, lncRNAs act as cis- or trans-regulators,
scaffolds, precursors for small RNAs, and structural RNAs to govern the
gene expression [38,39]. LncRNA interacts with mRNA to increase its
stability as well [28]. As a regulatory RNA, HULC is able to sponge
miR-372 [40]. Accordingly, we supposed that HULC might
upregulate CLOCK in a manner of direct interacting with
CLOCK mRNA. To test out hypothesis, we screened the sequences
of HULC and CLOCK. Intriguingly, we obtained a complementary
region between HULC and the 5'UTR of CLOCK mRNA, hinting
that HULC has potential to target CLOCK mRNA. Not
surprisingly, our experiments validated that the complementaryatoma cells in vivo. (A and B) Photographs of dissected tumors from
ght of tumors from mice. (D and E) Expression levels of HULC and
tissues from mice, respectively. Statistically significant differences
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responsible for the modulation of CLOCK mediated by HULC.
Moreover, we revealed that the levels of HULC were positively
correlated with those of CLOCK in clinical HCC tissues.
Hypermethylation in the CLOCK promoter reduced the risk of
breast cancer, and lower levels of CLOCK expression were documented
in healthy controls relative to normal or tumor tissue from patients with
breast cancer [41]. However, the role of CLOCK in hepatocarcinogen-
esis remains mysterious. On the basis of our observations, we are
inquisitive whether CLOCK is involved in the HULC-enhanced
development of HCC. Our results exhibited that CLOCK siRNA
effectively blocked the proliferation of hepatoma cells mediated by
HULC in vitro. Strikingly, CLOCK siRNA was able to remarkably
abrogate the HULC-facilitated tumor growth in nude mice as well,
indicating that CLOCK might be implicated in the HULC-promoted
tumor growth. A wave of studies reports that CLOCK participates in
the glucose and lipid homeostasis [42,43] and governs circadian
autophagy rhythm to impair the energy metabolism [44]. In addition,
CLOCK is a positive modulator of nuclear factor-κB–mediated
transcription to elicit the inflammatory process and regulates the
epigenome [11,45]. It is well known that the above phenomena are
pervasive in the development of tumorigenesis. Thereby, it suggests that
HULC might be involved in above functions in the development of
HCC through eliciting the expression of CLOCK. Potentially, HULC
may serve as a novel therapeutic target for HCC.
In aggregate, here we report that the HULC-modulated
disturbance of the circadian rhythm contributes to the hepatocarci-
nogenesis. Briefly, HULC heightens the expression of circadian
oscillator CLOCK, in which the complementary base pairing
between HULC and the 5'UTR of CLOCK mRNA underlies the
event. Notably, we observe that the overexpression of HULC results
in disordering the expression pattern and prolonging the periodic
expression of CLOCK in hepatoma cells. Moreover, we first provide
evidence that CLOCK is involved in the HULC-enhanced
proliferation of hepatoma cell in vitro and in vivo. Thus, our finding
provides new insights into the mechanism by which lncRNAs
modulate hepatocarcinogenesis through perturbing circadian rhythm.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2014.11.004.
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